Press Release: Sanofi and Novavax announce co-exclusive licensing agreement to co-commercialize COVID-19 vaccine and develop novel flu-COVID-19 combination vaccines
Related Articles
-
Marcos touts release of COVID-19 frontliners’ emergency allowance
President Marcos highlighted the distribution of the bulk of the pandemic emergency allowance to frontliners in his message for Health Workers’ Day, assuring members of the sector that the government values their service to the nation.?
-
AstraZeneca Withdraws Covid-19 Vaccine, Citing Lack of Demand
AstraZeneca Plc pulled its Covid-19 vaccine from the market due to lack of demand for a shot that initially raised hopes it would play a key role in protecting the world against the virus.
-
‘It’s car after car after car’: Police target dangerous intersections as traffic deaths rise
Nearly five months after the Las Vegas Metropolitan Police Department revealed the valley’s most dangerous intersections, agency data shows the danger has gotten worse, provoking targeted efforts that drivers may not see coming.